EyePoint, Inc. (EYPT)

Nasdaq: EYPT · Laboratory Analytical Instruments · Watertown, MA · filing with the SEC since 2005

Full chart Alerts Compare

Grade3.9

◀ Past 3.4● Present 3.5▶ Future 4.7

1 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2025, as filed

Revenue$31.4M-27.5%

Net income-$232M-77.2%

Earnings per share$-3.17-36.6%

Operating cash flow-$240M-90.2%

Cash$102M+2.1%

Debtn/a

Shareholders’ equity$306M-9.0%

Shares, diluted73.3M+30.1%

Return on equity-75.8%

The recordfrom its filings

Filings in 202670

Newest filingNov 12 · 10-Q

Annual reportMar 5, 2026

Quarterly reportNov 12, 2026

Next report due10-K by Mar 31

Insider sales, 12 months$1.1M

Insider buys, 12 months$100,000

Patents granted56

Filer categoryNon-accelerated filer<br>Smaller reporting company

Trailing twelve months to Sep 2026Revenue $2.6MNet income -$343MCash from operations -$295Mthe four newest filed quarters added

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

171819202122232425

As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 10-Q

Quarterly report

Open the filing on sec.gov

Nov 12, 2026 · SEC EDGAR · Form 8-K

Results released

Open the filing on sec.gov

Nov 4, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Oct 30, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Oct 27, 2026 · SEC EDGAR · Form SCHEDULE 13G

Large holder notice

Open the filing on sec.gov

Oct 19, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Oct 19, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Oct 7, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Sep 10, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Sep 8, 2026 · SEC EDGAR · Form SCHEDULE 13G

Large holder notice

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

EyePoint, Inc. is classed by the SEC under Laboratory Analytical Instruments (industry code 3826), based in Watertown, MA. License and Collaboration Agreement was 53% of fiscal 2025 revenue.

Newest on the record

Quarterly report on Nov 12. Before it, current report on Nov 12.

What is due next

The 10-K for the period to Dec 31, 2026, due by Mar 31, 2027.

About EYPT

EyePoint, Inc. is classed by the SEC under Laboratory Analytical Instruments (industry code 3826), based in Watertown, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $31 million and a loss of $232 million (its filed statements).

IndustryLaboratory Analytical Instruments

HeadquartersWatertown, MA

Business modelProduct business

ExchangeNasdaq

Filing since2005

Fiscal year endsDec 31

SEC number (CIK)1314102

Peers on fileQTRX, SEER, CTKB, LAB

Who runs it

Financial performance

In fiscal 2025 EyePoint’s revenue was $31.37 million, down 27.5% from $43.27 million the year before. It made a net loss of $232.0 million.

Annual report, filed Mar 5, 2026.

Financial statements

The grade

EyePoint grades 3.9 of 10 against its own industry, the 23 companies in Laboratory Analytical Instruments. Eight of the nine metrics are read as filed and one is an SI estimate, each with its reasoning.

◀ Past3.4

● Present3.5

▶ Future4.7

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton EYPT · research, not advice